300 related articles for article (PubMed ID: 5110948)
21. [The drug therapy effect on functional and organic stenocardias].
Gill E
Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
[No Abstract] [Full Text] [Related]
22. [Clinical study of verampamil in the treatment of patients with chronic coronary insufficiency].
Schvacabaja IK; Mjasnikov LA; Metelica VI; Grigorjanc RA; Dubinina LT
Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1478+. PubMed ID: 5536558
[No Abstract] [Full Text] [Related]
23. [A new 2-phase coronary agent for the treatment of angina pectoris due to coronary disease].
Gill E
Med Welt; 1978 Mar; 29(10):408-11. PubMed ID: 416316
[No Abstract] [Full Text] [Related]
24. [Protective effect of a beta-blockador on clinico-electrocardiographic manifestations in the coronary insufficiency apparent during Master's test: description of a clinical case].
Conti G; Piemontese M; Savarese A; Valva M
Clin Ter; 1969 Apr; 49(2):181-7. PubMed ID: 4401859
[No Abstract] [Full Text] [Related]
25. [Coronary therapy with Nitro-Sandolanid].
Toker Y
Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
[No Abstract] [Full Text] [Related]
26. [Clinical evaluation of the effects of beta-adrenergic blocking in heart diseases, with special reference to disorders of rhythm and circulation].
Fassini G; Saurgnani E; Agliati G; Marangoni R
Minerva Cardioangiol; 1967 Jan; 15(1):83-122. PubMed ID: 4386133
[No Abstract] [Full Text] [Related]
27. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
[No Abstract] [Full Text] [Related]
28. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
[No Abstract] [Full Text] [Related]
29. [Anti-anginal and anti-arrhythmic properties of amiodarone].
Rizzon P; Biasco G; Di Biase M; Antonelli G
Boll Soc Ital Cardiol; 1972; 17(7):413-7. PubMed ID: 4650836
[No Abstract] [Full Text] [Related]
30. [Beta adrenergic receptor blocking agents in the treatment of arrhythmia and angina pectoris].
Fülöp T; Szodoray P
Orv Hetil; 1969 Oct; 110(41):2387-94. PubMed ID: 5358359
[No Abstract] [Full Text] [Related]
31. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
Willems D; Frisch P; Klepzig H
Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
[No Abstract] [Full Text] [Related]
32. [Initial clinical results of N-(3-isoamyloxy, 2-(3,4,5-trimethoxy) benzoyloxy) propyl tetrahydro 1,4-oxazine hydrochloride on coronary pain and disorders of rhythm].
Pernod J; Kermarec J
Therapie; 1969; 24(4):675-82. PubMed ID: 5822249
[No Abstract] [Full Text] [Related]
33. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
Warembourg H; Théry C
Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
[No Abstract] [Full Text] [Related]
34. [Coronary therapy in geriatrics].
Grübl M; Klein K; Siedek H
Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
[No Abstract] [Full Text] [Related]
35. [Antiarrhythmic effect of butidrine: experimental study on arrhythmias induced by N-adrenaline in halothane anesthesia].
Rossano C; Romoli M; Brunozzi LT; Monti GB; Pavoni P
Acta Anaesthesiol; 1969; 20(4):663-700. PubMed ID: 4397385
[No Abstract] [Full Text] [Related]
36. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
[No Abstract] [Full Text] [Related]
37. [Clinical study of a new beta adrenergic blockader: Pindolol].
Faivre G; Petitier H; Dodinot B; Hua G
Coeur Med Interne; 1972; 11(1):167-74. PubMed ID: 4401293
[No Abstract] [Full Text] [Related]
38. [Therapy with beta-blocking agents in cardiology].
Dal Palù C
Minerva Med; 1970 Nov; 61(95):5450-8. PubMed ID: 4395227
[No Abstract] [Full Text] [Related]
39. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
Hagel H
Fortschr Med; 1981 Nov; 99(41):1714-7. PubMed ID: 7319440
[TBL] [Abstract][Full Text] [Related]
40. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome].
Cristiano P; Panzitta S; Cuiuli V; Petronio A; Giraldi A
Minerva Gastroenterol; 1973; 19(4):259-69. PubMed ID: 4592525
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
